MedPath

What is the best cycle preparation for transferring a thawed embryo: a natural cycle or a cycle with hormonal medication?

Phase 1
Conditions
Patients with subfertility having frozen embryos after in vitro fertilization (IVF) or intracytoplasmatic sperm injection (ICSI)
Therapeutic area: Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
Registration Number
EUCTR2018-001014-15-BE
Lead Sponsor
university hospital leuven
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Female
Target Recruitment
554
Inclusion Criteria

Women undergoing FET after a first, second or third fresh IVF/ICSI cycle
Single embryo transfer (SET) or Double embryo transfer (DET)
Female age between 18-45 year
Women having a natural ovulatory cycle (24-35 days)
Normal uterine cavity (fundal indentation at the cavity <10mm)

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 554
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Use of donor gametes
BMI > or equal to 35 kg / m2
Any contra-indication to estrogen or progesterone supplementation (e.g. history of thrombosis, prior or current hormone-sensitive malignancy…)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath